azacitidine in the treatment of mds
Published 4 years ago • 2.4K plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
3:03
venetoclax and 5-azacytidine for the treatment of mds and cmml
-
4:44
establishing the clinical benchmark of azacitidine in patients with mds
-
2:47
combination therapies with azacitidine for mds
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
1:31
advances in mds treatment: the promise of magrolimab plus azacitidine
-
1:31
pevaz update: pevonedistat & azacitidine in r/r mds and mds/mpn after dnmti failure
-
2:00
optimizing hma treatment in hr-mds: azacitidine versus decitabine
-
1:43
targeting mds stem cells with omacetaxine and azacitidine
-
3:28
preclinical studies of tasquinimod in mds: in vitro and in vivo investigations
-
2:39
a phase ii trial of ruxolitinib and azacitidine combination therapy in patients with myelofibrosis
-
7:11
treatment of older mds patients with bmt (bone marrow transplantation)
-
2:43
novel therapies in the future of mds treatment
-
0:44
mds: an update on pevonedistat plus azacitidine
-
2:50
magrolimab azacitidine in untreated higher-risk mds
-
2:20
pevonedistat, azacitidine and venetoclax triplet therapy for aml, mds and cmml
-
5:36
venetoclax and azacitidine in mds patients
-
3:51
venetoclax plus azacitidine in treatment-naïve and r/r mds
-
5:22
magrolimab azacitidine in mds and aml
-
6:01
treatment of myelodysplastic syndromes (mds)
-
1:45
updates on the treatment of mds
-
0:47
tamibarotene combined with azacitidine and venetoclax to treat aml and mds with rara abnormalities
-
1:13
the use of azacitidine in hr-mds and the potential of combination therapies